Advertisement
Advertisement
U.S. Markets open in 1 hr 39 mins
Advertisement
Advertisement
Advertisement
Advertisement

Theratechnologies Inc. (TH.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
3.6800+0.0800 (+2.22%)
At close: 04:00PM EST
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close3.6000
Open3.4700
Bid3.6000 x 0
Ask3.7000 x 0
Day's Range3.4700 - 3.7000
52 Week Range2.7200 - 5.6100
Volume42,128
Avg. Volume30,864
Market Cap350.047M
Beta (5Y Monthly)1.68
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
  • GlobeNewswire

    Theratechnologies Submits Supplemental Biologics License Application to FDA Advancing Development of IV Push Trogarzo® for Patients Living With HIV

    sBLA submission with FDA follows on the back of recently announced positive TMB-302 study resultsMONTREAL, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies or Company) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, is pleased to announce the submission of a supplemental biologics license application (sBLA) to the U.S. Food and Drug Administration (FDA) for the Company’s intravenous (IV) pu

  • GlobeNewswire

    Theratechnologies Named Recipient of the 2021 ADRIQ Innovation Award in the "Life Sciences" Category

    MONTREAL, Nov. 26, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies, or Company) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, is pleased to announce that it was awarded of the 2021 Innovation Award in the “Life Sciences” category at the 31st ADRIQ Innovation Awards Gala held on November 25, 2021. Every year, the ADRIQ (Association pour le développement de la recherche et de l'innovation du Québec

  • CNW Group

    Theratechnologies Announces Renewal of Shelf Prospectus and Registration Statement; At-The-Market Facility to be Extended

    Theratechnologies Inc. ("Theratechnologies" or the "Company") (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that it has filed a preliminary short form base shelf prospectus with the securities regulatory authorities of all the provinces of Canada and a corresponding shelf registration statement with the United States Securities and Exchange Commission (the "SEC") on Form F-10.

Advertisement
Advertisement